BFSG LLC’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1
Closed -$73 – 646
2024
Q1
$73 Buy
+1
New +$74 ﹤0.01% 650

Other funds holding MTRI

BFSG LLC's MTRI Position: Q2 2024 in Review

BFSG LLC sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2024, closing a stake of 1 share — an estimated $73 sold.

BFSG LLC first reported a position in MTRI in Q1 2024 and held it in 1 quarter. The position peaked at $73 in Q1 2024. 7 funds tracked by Wall St. Rank hold MTRI as of Q2 2024.

  • BFSG LLC reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BFSG LLC sold 1 Mentari Therapeutics, Inc. Common Stock share in Q2 2024, an estimated $73.
  • BFSG LLC first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • BFSG LLC's Mentari Therapeutics, Inc. Common Stock position peaked at $73 in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.